Literature DB >> 29450749

An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia.

Arul Thomas1, David Koch2, William Marsteller3, David Lewin4, Adrian Reuben3.   

Abstract

BACKGROUND: Gastric antral vascular ectasia (GAVE) commonly presents as linear striped ("watermelon stomach") or punctate phenotypes, to which a newly discovered nodular form was recently added. AIMS: We performed a retrospective cohort study to detail and compare the clinical and histological characteristics of major GAVE phenotypes.
METHODS: In 136 GAVE patients (tertiary care ambulatory and inpatient, median age 61.3 years, 73 men, and 63 women), clinical and laboratory results were recorded, with comorbidities, endoscopy indications, and complications of cirrhosis. In 74 patients, GAVE histopathology was cataloged by a pathologist masked to endoscopy results.
RESULTS: Median age 61.3 years, 73 men, and 63 women. GAVE phenotypes were: linear striped-62 (46%), punctate-32 (24%), and nodular-41 (30%). Endoscopy was commonly performed for variceal screening in linear striped (45%) and nodular (34%) GAVE and for gastrointestinal bleeding in punctate (41%) and nodular (29%) GAVE, respectively. Of 89 cirrhotic patients, 37.5% each had linear striped or nodular GAVE, 24.7% had punctate forms (p = 0.03). Child-Turcotte-Pugh and Model for End-Stage Liver Disease scores were similar among phenotypes. Histologically, reactive epithelial hyperplasia and vascular ectasia were universal; smooth muscle proliferation was more common and consistent (78-86%) than microvascular thrombi (27-59%) and fibrohyalinosis (18-53%), which each varied with phenotype.
CONCLUSIONS: Nodular GAVE is a gastric mucosal abnormality that is similar to the linear striped and punctate phenotypes, yet has distinct clinical and histological features. Increased awareness of nodular GAVE by endoscopists is needed to avoid its misdiagnosis as nonspecific antral nodules.

Entities:  

Keywords:  Cirrhosis; Gastric nodules; Gastrointestinal bleeding

Mesh:

Year:  2018        PMID: 29450749     DOI: 10.1007/s10620-018-4965-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  The honeycomb stomach: coalesced gastric angiodysplasia.

Authors:  S K Chawla; K Ramani; P Lo Presti
Journal:  Gastrointest Endosc       Date:  1990 Sep-Oct       Impact factor: 9.427

2.  The biopsy GAVE the diagnosis.

Authors:  William F Marsteller; David N Lewin; Adrian Reuben
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-23       Impact factor: 11.382

Review 3.  The management of portal hypertensive gastropathy and gastric antral vascular ectasia.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Dig Liver Dis       Date:  2010-11-20       Impact factor: 4.088

4.  Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE).

Authors:  J S Baudet; H Salata; M Soler; V Castro; D Díaz-Bethencourt; M Vela; S Morales; J Avilés
Journal:  Endoscopy       Date:  2007-02       Impact factor: 10.093

5.  Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy.

Authors:  S C Abraham; V K Singh; J H Yardley; T T Wu
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

6.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

7.  The 'mosaic-like' pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapy.

Authors:  K Kotzampassi; E Eleftheriadis; H Aletras
Journal:  J Gastroenterol Hepatol       Date:  1990 Nov-Dec       Impact factor: 4.029

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

Review 9.  Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

Authors:  J L Payen; P Calès; J J Voigt; S Barbe; C Pilette; L Dubuisson; H Desmorat; J P Vinel; A Kervran; J A Chayvialle
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

10.  Grading portal gastropathy: validation of a gastropathy scoring system.

Authors:  Charmaine A Stewart; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2003-08       Impact factor: 10.864

View more
  3 in total

1.  The misclassification of gastric antral vascular ectasia.

Authors:  Mahmoud Aryan; Ravi Jariwala; Basem Alkurdi; Shajan Peter; Mohamed Shoreibah
Journal:  J Clin Transl Res       Date:  2022-05-25

2.  The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology.

Authors:  Randa Salah Eldin Abdelmoneim; Amr Aly Abdelmoety; Nahed Baddour; Perihan Salem; Marwa Metawea
Journal:  Egypt Liver J       Date:  2022-06-10

Review 3.  Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review.

Authors:  Mengyuan Peng; Xiaozhong Guo; Fangfang Yi; Fernando Gomes Romeiro; Andrea Mancuso; Xingshun Qi
Journal:  Adv Ther       Date:  2021-09-15       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.